IPO Headline
Quick Pointers
- Promoters and Promoter group owns 67.9% pre-offer equity shareholding.
- Domestic focused business of scale with potential for growth
- Domestic Sales growing at 1.3 times the growth rate of the IPM between the Financial Year 2020 and MAT December 2022
- Several products in portfolio with top 10 rankings across key therapeutic areas
- Established consumer healthcare franchise with brand recall
- Leveraged corporate brand to build and scale brands like Manforce Condoms, Prega News, Gas-O-Fast, Nurokind, Telmikind amongst others
Advertisement
IPO Quick Snapshot
About Company
Mankind Pharma is India’s fourth largest pharmaceutical company in terms of Domestic Sales and third largest in terms of sales volume for moving annual total (“MAT”) December 2022 (Source: IQVIA Dataset, IQVIA TSA MAT December 2022 Dataset for India (For FY20-22)). Company is focused on the Indian domestic market, where we develop, manufacture and market a diverse range of pharmaceutical formulations as well as several consumer healthcare products.
About Industry
"The size of the Indian pharmaceutical market increased (“IPM”) at a compounded annual growth rate (“CAGR”) of approximately 10.90% from ₹660.53 billion in the Financial Year 2012 to ₹1,859.05 billion in the Financial Year 2022, and is forecast to further grow at a CAGR of 10% – 11% to reach ₹3,000 – ₹3,100 billion by the Financial Year 2027. The key factors affecting the growth of the IPM are rising income levels, increasing life expectancy, growth in lifestyle diseases and government initiatives. The consumer healthcare market in India has witnessed and is expected to continue to witness value growth in the range of 10-11%, mainly driven by new lifestyle patterns leading to disorders/diseases, consumer awareness on preventive healthcare, and an increase in consumer income level and expenditure on consumer healthcare products. (Source: IQVIA Report)"
Promoters of company are Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust And Prem Sheetal Family Trust. Promoter and Promoter group owns 67.9% of the pre-offer equity shares of the company.
IPO Key Details:
IPO Dates
Advertisement
IPO Issue and Subscription Details
Financials
Valuation
IPO Lead Manager Details
IPO Registrar and Transfer Agent (RTA) Details
Check Allotment Status of Mankind Pharma IPO
| Please check below or visit here to check allotment status of IPO |
Source: DRHP, RHP, Company, Company Website | Logo/Images published in the article may be copyright of respective companies.
The objects of the Offer are to (i) carry out the Offer for Sale of 40,058,844 Equity Shares by the Selling Shareholders aggregating to ₹ [●] million; and (ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Company profile and about company
Company profile and about company
Advertisement
Posts
0 Comments